These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 33255258)

  • 1. Pathogenetic Mechanisms Implicated in Sjögren's Syndrome Lymphomagenesis: A Review of the Literature.
    Stergiou IE; Poulaki A; Voulgarelis M
    J Clin Med; 2020 Nov; 9(12):. PubMed ID: 33255258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive markers of lymphomagenesis in Sjögren's syndrome: From clinical data to molecular stratification.
    Kapsogeorgou EK; Voulgarelis M; Tzioufas AG
    J Autoimmun; 2019 Nov; 104():102316. PubMed ID: 31431317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Lymphoproliferative disorders in Sjögren's syndrome].
    Prochorec-Sobieszek M; Wagner T
    Otolaryngol Pol; 2005; 59(4):559-64. PubMed ID: 16273862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereotypic rheumatoid factors that are frequently expressed in mucosa-associated lymphoid tissue-type lymphomas are rare in the labial salivary glands of patients with Sjögren's syndrome.
    Bende RJ; Slot LM; Hoogeboom R; Wormhoudt TA; Adeoye AO; Guikema JE; van Noesel CJ
    Arthritis Rheumatol; 2015 Apr; 67(4):1074-83. PubMed ID: 25546553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malignant lymphoma in primary Sjögren's syndrome: an update on the pathogenesis and treatment.
    Routsias JG; Goules JD; Charalampakis G; Tzima S; Papageorgiou A; Voulgarelis M
    Semin Arthritis Rheum; 2013 Oct; 43(2):178-86. PubMed ID: 23816048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenetic mechanisms in the initiation and perpetuation of Sjögren's syndrome.
    Voulgarelis M; Tzioufas AG
    Nat Rev Rheumatol; 2010 Sep; 6(9):529-37. PubMed ID: 20683439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathological features of lymphoid proliferations of the salivary glands: lymphoepithelial sialadenitis versus low-grade B-cell lymphoma of the malt type.
    Carbone A; Gloghini A; Ferlito A
    Ann Otol Rhinol Laryngol; 2000 Dec; 109(12 Pt 1):1170-5. PubMed ID: 11130833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphomas in patients with Sjögren's syndrome: review of the literature and physiopathologic hypothesis.
    Mariette X
    Leuk Lymphoma; 1999 Mar; 33(1-2):93-9. PubMed ID: 10194125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphomas complicating primary Sjögren's syndrome: from autoimmunity to lymphoma.
    Nocturne G; Pontarini E; Bombardieri M; Mariette X
    Rheumatology (Oxford); 2021 Aug; 60(8):3513-3521. PubMed ID: 30838413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokine markers of B lymphocytes in minor salivary gland infiltrates in Sjögren's syndrome.
    Navarro-Mendoza EP; Aguirre-Valencia D; Posso-Osorio I; Correa-Forero SV; Torres-Cutiva DF; Loaiza D; Tobón GJ
    Autoimmun Rev; 2018 Jul; 17(7):709-714. PubMed ID: 29729452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphoproliferative disorders in Sjögren's syndrome.
    Masaki Y; Sugai S
    Autoimmun Rev; 2004 Mar; 3(3):175-82. PubMed ID: 15110228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CXCL13 and CCL11 Serum Levels and Lymphoma and Disease Activity in Primary Sjögren's Syndrome.
    Nocturne G; Seror R; Fogel O; Belkhir R; Boudaoud S; Saraux A; Larroche C; Le Guern V; Gottenberg JE; Mariette X
    Arthritis Rheumatol; 2015 Dec; 67(12):3226-33. PubMed ID: 26359802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update on Sjögren's syndrome autoimmune epithelitis: from classification to increased neoplasias.
    Tzioufas AG; Voulgarelis M
    Best Pract Res Clin Rheumatol; 2007 Dec; 21(6):989-1010. PubMed ID: 18068857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphoid proliferations of the salivary glands.
    Harris NL
    Am J Clin Pathol; 1999 Jan; 111(1 Suppl 1):S94-103. PubMed ID: 9894474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clonal B-cell reaction in Sjögren disease and Hashimoto autoimmune thyroiditis].
    Tiemann M; Asbeck R; Wacker HH
    Pathologe; 1996 Jul; 17(4):289-95. PubMed ID: 8927595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting lymphoma development in patients with Sjögren's syndrome.
    De Vita S; Gandolfo S
    Expert Rev Clin Immunol; 2019 Sep; 15(9):929-938. PubMed ID: 31347413
    [No Abstract]   [Full Text] [Related]  

  • 17. Secondary tumours in Sjögren's syndrome.
    Kovács L; Szodoray P; Kiss E
    Autoimmun Rev; 2010 Feb; 9(4):203-6. PubMed ID: 19602455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salivary gland B cell lymphoproliferative disorders in Sjögren's syndrome present a restricted use of antigen receptor gene segments similar to those used by hepatitis C virus-associated non-Hodgkins's lymphomas.
    De Re V; De Vita S; Gasparotto D; Marzotto A; Carbone A; Ferraccioli G; Boiocchi M
    Eur J Immunol; 2002 Mar; 32(3):903-10. PubMed ID: 11870635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular pathology assists the diagnosis of lymphoepithelial sialadenitis, Sjögren's syndrome and extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue.
    Chi Y; Zhang Q; Qin Z; Bai J; Yan J; Liu C; Li B
    J Dent Sci; 2024 Jan; 19(1):130-138. PubMed ID: 38303804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of B cell lymphoma in patients with Sjögren's syndrome and hepatitis C virus infection.
    Ramos-Casals M; la Civita L; de Vita S; Solans R; Luppi M; Medina F; Caramaschi P; Fadda P; de Marchi G; Lopez-Guillermo A; Font J;
    Arthritis Rheum; 2007 Feb; 57(1):161-70. PubMed ID: 17266090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.